Skip to content
Search AI Powered

Latest Stories

New York Cannabis Regulators Face Accountability Questions Amidst Rollout Challenges

New York Cannabis Regulators Face Accountability Questions Amidst Rollout Challenges
New York Cannabis Regulators Face Accountability Questions Amidst Rollout Challenges

New York's cannabis program rollout has been marred by controversies and challenges from the start. A private meeting held yesterday by regulators aimed to address the grievances of industry stakeholders and provide updates on the state's initiatives. However, what started as a hopeful gathering quickly turned into a heated exchange, with attendees expressing frustration over the lack of financial transparency from top officials, reported Cannabis Insider.

The meeting, which lasted two hours and involved Conditional Adult-Use Retail Dispensary (CAURD) licensees, the Office of Cannabis Management (OCM), and the Dormitory Authority of the State of New York (DASNY), unveiled several new initiatives. These initiatives include a modified loan program for CAURD holders, changes to DASNY's turnkey storefronts, and the introduction of a database for checking zoning locations.


While the announcement of a $5 million loan program offering up to $100,000 for CAURD holders opting out of turnkey storefronts is a step in the right direction, concerns about financial accountability remain. The lack of collateral requirements and the 5% interest rate provide much-needed support for license holders facing the challenges of securing low-interest funding in a market known for tough banking practices and predatory lenders. However, questions arise regarding the clarity of loan costs and the absence of itemized receipts for high build-out expenses, as raised by Carson Grant during the meeting.

Additionally, regulators' decision to slow down the acquisition of turnkey storefronts and implement price caps for DASNY build-outs aims to address concerns raised by CAURD license holders. Many have complained about the exorbitant prices for turnkey storefronts, which far exceed normal construction quotes. While the intention behind these measures is to level the playing field and prevent competition between DASNY and license holders, there are concerns about potential delays and the impact on the timeline for stores to become operational.

Another significant change involves the zoning approval process. Regulators introduced an interactive map to help CAURD holders check zoning requirements and identify if other dispensaries have secured locations in their desired neighborhoods. Furthermore, OCM and DASNY will no longer jointly vet properties, streamlining the approval process. These changes are welcomed by license holders as they offer increased information and potentially faster approvals. However, there remains a need for clear guidelines on how applicants will be ranked and graded for location selection.

Despite the mixed opinions among CAURD members following the meeting, there is a general acknowledgment of the open conversation and dialogue fostered by the OCM and DASNY. The anxiety of opening stores before general licenses and larger corporations enter the market is palpable among license holders. The first-mover advantage hangs in the balance, and any delays could prove detrimental to their businesses.

It is crucial for regulators to recognize the urgency and financial challenges faced by license holders, particularly those from marginalized communities and with limited access to startup capital. The social equity fund and state-funded build-outs can provide a lifeline for these individuals, but the application process must be streamlined and transparent. License holders like Osbert Orduña emphasize that they need this support to succeed and contribute to their communities.

Transparency and accountability are paramount in ensuring the success and fairness of New York's cannabis program. License holders are investing their time, money, and livelihoods, and they deserve clear communication, financial transparency, and timely decision-making. As the industry evolves, ongoing dialogue between regulators and license holders is crucial to address challenges, promote equity, and foster a thriving cannabis market in New York.

The regulators' commitment to pivot and refine the program is a positive sign, but actions must speak louder than words. The state's mandate to support license holders must be backed by concrete steps and effective implementation. It is essential for regulators to not only listen but also to act on the feedback and concerns raised by industry stakeholders.

The frustration expressed by attendees at the meeting is a clear indication that there is a need for greater financial accountability and transparency from regulatory bodies. License holders have the right to expect clear and itemized cost breakdowns, timely information, and a streamlined process for accessing funding and securing locations. Building trust between regulators and the industry is crucial for the long-term success of New York's cannabis program.

While it is commendable that the OCM and DASNY are willing to hold an open dialogue, more needs to be done to address the challenges faced by license holders. The concerns raised by Carson Grant and Galina German-Innes highlight the urgent need for improved communication and financial clarity. License holders should not have to resort to passionate speeches and public confrontations to get the answers they deserve. Transparency means providing accurate and detailed information, actively addressing concerns, and ensuring that the financial processes are fair and equitable.

As the state continues to navigate the complexities of the cannabis industry, it is important to learn from the missteps and challenges of the rollout thus far. The state must acknowledge that rushing the process without proper planning and infrastructure can have long-lasting consequences. A measured and strategic approach, based on the experiences of other states, can help New York avoid repeating the same mistakes and create a robust and thriving cannabis market.

Furthermore, the state must prioritize supporting license holders from marginalized communities and those with limited resources, such as the farming or cultivation side of the industry, which is often the least understood and least heard. The social equity fund and state-funded build-outs are vital tools for empowering these individuals and addressing historical injustices. Streamlining the application process and ensuring that funds are accessible in a timely manner can make a significant difference in promoting diversity, inclusivity, and economic opportunities in the cannabis industry.

In conclusion, New York's cannabis program is at a critical juncture. The recent meeting held by regulators was an opportunity to address the concerns and frustrations of license holders. While some positive steps were announced, such as the loan program and changes to the zoning approval process, there is still much work to be done. Regulators must prioritize financial accountability, transparency, and effective communication to instill confidence in the industry and support license holders in their efforts to establish successful businesses.

The state's commitment to listening and fine-tuning the program is commendable, but it must be followed by concrete actions and a commitment to rectify past shortcomings. By fostering an environment of collaboration, trust, and accountability, New York can create a cannabis program that not only benefits the industry but also serves as a model for other states to follow. The success of the program depends on the collective efforts of regulators, license holders, and community stakeholders working together to build a thriving and equitable cannabis industry in the Empire State.

More For You

Lights, Camera, Cannabis: The New Theater Experience
Cigar smoking in a bar....
Giphy

NY Movie Theaters: High on Cannabis Lounges

In the dimly lit ambiance of New York City's historic movie theaters, the scent of buttered popcorn has long been the olfactory hallmark. However, as cannabis legalization sweeps across the state, a provocative question emerges: Could the future of cinema include the aroma of cannabis alongside the traditional concessions?

The Current Landscape of Cannabis Consumption Lounges

New York State’s Clean Indoor Air Act (CIAA) casts a long shadow over this budding idea. Enacted to safeguard public health, the CIAA prohibits smoking and vaping in most indoor workplaces, encompassing bars, restaurants, and, notably, movie theaters. The act defines smoking expansively, including the burning of tobacco, cannabis, or cannabinoid-hemp products. Violations can result in fines up to $2,000 for each infraction, underscoring the state’s commitment to maintaining smoke-free public spaces.

Keep ReadingShow less
IN SUPPORT OF CANNABIS REFORM FOR VETERANS, AMERICAN WEED COMPANY PLANS VISIT TO CAPITOL HILL
IN SUPPORT OF CANNABIS REFORM FOR VETERANS, AMERICAN WEED COMPANY PLANS VISIT TO CAPITOL HILL
IN SUPPORT OF CANNABIS REFORM FOR VETERANS, AMERICAN WEED COMPANY PLANS VISIT TO CAPITOL HILL

Pentagon bets $10M on MDMA for PTSD

The U.S. Department of Defense (DoD) has earmarked $9.8 million for pioneering research into the therapeutic potential of psychedelics, specifically MDMA, for active-duty service members grappling with post-traumatic stress disorder (PTSD). This initiative underscores a significant shift in military mental health strategies, acknowledging the pressing need for innovative treatments amid rising concerns over service members' well-being.Latest news & breaking headlines+1Military Times+1

Breaking Down the Investment

Keep ReadingShow less
Kanye West Is Spiraling—And Our Mental Health System Is Letting It Happen - The Bluntness
Kanye West Is Spiraling—And Our Mental Health System Is Letting It Happen - The Bluntness
Photo by Axel Antas-Bergkvist on Unsplash

Kanye West Is Spiraling—And Our Mental Health System Is Letting It Happen - The Bluntness

Kanye West, aka Ye, isn’t just trending—he’s unraveling in real time. And instead of intervention, we get viral clips, condemnation, and an audience watching a man self-destruct. His latest stunt? Airing a Super Bowl ad promoting a swastika-emblazoned Yeezy shirt on his site—a move so blatantly antisemitic that even the most die-hard supporters had to step back. This act garnered significant media coverage, leading to brands cutting ties and agents dropping him. His social media account faced scrutiny and was ultimately deleted after a history of controversial postings. But here’s the problem: canceling Kanye doesn’t fix Kanye.

At this point, the question isn’t whether his actions are inexcusable (they are). The question is, what happens when one of the world’s most influential figures is also one of the most untreated cases of mental illness in pop culture history?

Keep ReadingShow less
Comprehensive Glossary of Cannabis Terminology - The Bluntness
Cannabis Terminology - The Bluntness
Photo by Margo Amala on Unsplash

Are You Ready to Master Cannabis Lingo? Explore Essential Terms Now

This glossary covers key cannabis-related terms that can help consumers better understand the cannabis industry, products, and their effects. Whether you're new to cannabis or looking to deepen your knowledge, these definitions offer clarity on common terms you might encounter.

Cannabis Basics: What is Cannabis?

Cannabis is a fascinating plant species that includes three main types: Cannabis sativa, Cannabis indica, and Cannabis ruderalis. Each of these species has unique characteristics and effects. The cannabis plant is a complex organism, rich in various compounds such as cannabinoids, terpenes, and flavonoids. These compounds contribute to the plant’s diverse range of effects and therapeutic benefits. Cannabis plants are cultivated for both medicinal and recreational purposes, and they can be consumed in multiple forms, including dried flower, extracts, and edibles. Whether you’re interested in the energizing effects of Cannabis sativa, the relaxing properties of Cannabis indica, or the unique traits of Cannabis ruderalis, there’s a cannabis plant to suit every need.

Cannabis Products: Cannabis Extracts

Cannabis extracts are highly potent products derived from the cannabis plant using various extraction methods, such as solvents or CO2. These extracts are concentrated forms of cannabis that can be used in several ways, including dabbing, vaporizing, or as ingredients in edibles and topicals. There are several types of cannabis extracts, each with its own texture and potency, including wax, shatter, oil, and crumble. These products are often favored for their high cannabinoid content and are commonly used for medicinal purposes, such as pain relief and anxiety management. Whether you’re looking for a powerful dabbing experience or a potent ingredient for your homemade edibles, cannabis extracts offer a versatile and effective option.

Keep ReadingShow less
Cannabis and Aging: A Groundbreaking Study Challenges Long-Held Beliefs - The Bluntness
Cannabis and Aging: A Groundbreaking Study Challenges Long-Held Beliefs - The Bluntness
Giphy

Aging & Cannabis: New Findings

For decades, cannabis has been widely regarded as a substance with potential cognitive risks, particularly when used over long periods. Governments across the globe have classified it as a controlled substance, citing concerns about the effects of marijuana use, including memory loss, diminished executive function, and long-term neurological impact. But new research is challenging this long-standing assumption, suggesting that cannabis use may not be linked to age-related cognitive decline—and might even be associated with better cognitive preservation over time.

A recent study published in PubMed (NIH, 2024) followed over 5,000 men for more than four decades to analyze the long-term cognitive effects of cannabis use. The results? Men with a history of cannabis use experienced less cognitive decline from early adulthood to late midlife compared to those who never used cannabis.

Keep ReadingShow less